ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Announces a Publication in the Peer-Reviewed Journal, Aging, Linking Inflammasome NLRP3 Activation with Age-Related Structural Changes in the Kidney and Reduced Kidney Function
18 oct. 2023 07h05 HE | ZyVersa Therapeutics
Inflammasome NLRP3 activation is associated with an age-related decline in kidney health, which is compounded in the presence of kidney disease.
Tarnopolsky + product suite
A Game Changer: Exerkine Corporation Leap Frogs into its Commercial Phase
17 oct. 2023 05h32 HE | Exerkine Corporation
A Game Changer: Exerkine Corporation Leap Frogs into its Commercial Phase.
22157.jpg
Global Healthcare Socioeconomic Development Report 2023: Digitalization, Policy Impetus, and Localized Manufacturing Drive Growth Opportunities in the Healthcare and Allied Sectors
03 oct. 2023 09h58 HE | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Socioeconomic Development: Healthcare Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.Despite a subdued economic...
SRI Management Welcomes South Carolina Property To Extensive Portfolio
02 oct. 2023 21h55 HE | SR Companies
SRI Management, in conjunction with Bourne Financial Group, gladly announces Vineyard Bluffton as the next senior living to join their portfolio.
cmi_logo.png
[Latest] Global Recombinant Human Insulin Market Size/Share Worth USD 55.99 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 août 2023 16h30 HE | Custom Market Insights
Austin, TX, USA, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Recombinant Human Insulin Market Size, Trends and Insights By Product (Regular...
Logo Blue Main.png
Neuronascent Announces NIA Grant Award for NNI-362 to Reach Phase 2 Clinical Trials for Mild to Moderate Alzheimer’s Disease
22 août 2023 06h00 HE | Neuronascent, Inc.
ROCKVILLE, Md., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the National Institute of Aging (NIA), has...
National Evaluation
National Evaluation Project Ramps Up Emerging Strategies to Improve Health Outcomes for People Aging with HIV
07 août 2023 09h00 HE | NORC at the University of Chicago
Chicago, IL, Aug. 07, 2023 (GLOBE NEWSWIRE) -- NORC at the University of Chicago will lead a new national initiative with the New York State Department of Health / Health Research Inc (HRI) to...
U.S. Memory Care Market
Revolutionizing Memory Care: Latest Innovations to Support Aging Americans in 2023 - Featuring Top Players Brookdale, Sunrise, Azura Memory Care and More
24 juil. 2023 04h58 HE | Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "U.S. Memory Care Market, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.U.S. Memory Care Market to Reach USD 8.61 Billion by...
Global Market for Healthcare Fabrics
Global Healthcare Fabrics Strategic Business Report 2023: Stable Infant Diaper Sales Propels Demand for Healthcare Fabrics
07 juil. 2023 06h08 HE | Research and Markets
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "Healthcare Fabrics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Healthcare...
Logo Blue Main.png
Neuronascent to Present New Parkinson’s Model Data at AAIC 2023 for the Alzheimer’s Disease Investigational Therapy, NNI-362
28 juin 2023 06h00 HE | Neuronascent, Inc.
ROCKVILLE, Md., June 28, 2023 (GLOBE NEWSWIRE) -- Neuronascent Inc., today announced its abstract titled, Clinical Stage Alzheimer’s therapy, NNI-362 Promotes TH+ Neurons Associated with a Reversal...